System for automatic feedback-controlled administration of drugs

• US 4,280,494 A
• Filed: 06/26/1979
• Issued: 07/28/1981
• Est. Priority Date: 06/26/1979
• Status: Expired due to Term

• Current Assignee: Robert J. Cosgrove Jr, Victor F. Smolen
• Original Assignee: Robert J. Cosgrove Jr, Victor F. Smolen
• Inventors: Cosgrove, Robert J. Jr., Smolen, Victor F.
• Primary Examiner(s): Kamm, William E.
• Application Number:
  US06/052,242
• Time in Patent Office: 763 Days
• Field of Search: 128/213, 128/214 E, 128/214 F, 128/260, 128/731
• US Class Current: 604/503
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00

Abstract

A system for automatic feedback controlled administration of drugs (SAFCAD) is disclosed for the control of administration of drugs responsive to real-time processed physiological or pharmacological signals. Control apparatus implemented by analog, digital, or optimal-adaptive digital means is described using various combinations of proportional, integral and derivative control loop processes. A preferred digital embodiment uses optimal-adaptive, proportional-integral control which includes on-line physiological system modeling and control loop parameter tuning for the administration of anesthetics such as thiopental.

Claims

1. Automatic feedback controlled apparatus for administering drugs to a subject to achieve a desired level of anesthesia, comprising:

(a) means for sensing the subject'"'"'s EEG signal and for producing a response signal corresponding to said EEG signal;

(b) means for administering said drugs to the subject responsive to an actuating signal;

(c) preset means for establishing an order signal corresponding to the desired level of anesthesia;

(d) digital means connected to said sensing means, said means for administering and to said response signal producing means for identifying the drug/subject system model between said drug and said subject and for producing controller signals corresponding to said identified relationship; and

(e) a digital control loop connected to said means for sensing, means for administering, preset means and said digital means, for processing a difference signal, formed between said response signal and said order signal by a comparator, into a proportional component and an integral component of said difference signal to comprise said actuating signal, and further having means for establishing the ratio of proportional and integral components by said controller signals.

2. The apparatus of claim 1, wherein said digital control loop further comprises means for processing said difference signal into proportional and derivative components of said difference signal, which components are combined to produce said actuating signal, wherein the ratio of said proportional and derivative components is determined in substantial part by said controller signals.

3. The apparatus of claim 1 wherein said digital control loop further comprises programmable digital means for processing said difference signal into a proportional component, an integral component, and a derivative component of said difference signal and means for combining said components to produce said actuating signal, wherein the ratio of said proportional and integral and derivative components is determined in substantial part by said controller signals.

4. The apparatus of claim 1 wherein said means for identifying the drug/subject system model implements circuitry for quantifying the process reaction according to the equation ##EQU4## wherein B_u is the ultimate gain and u(t-T_d) symbolizes a unit step function with time delay T_d, M is the drug dose rate, and S is the slope of the response curve at its point of inflection.

5. The apparatus of claim 1 wherein said drug is thiopental.

6. A method for administering drugs to a subject to achieve a desired level of anesthesia for an extended period, comprising the steps of:

(a) establishing a desired level of anesthesia to be attained and converting this into an order signal;

(b) administering a controlled flow of drugs to said subject by controllable administering means;

(c) sensing and processing the subject'"'"'s EEG signal to obtain a power response signal corresponding to the total power contained in the EEG signal;

(d) determining the drug/subject system model between the administered drug and said subject by applying a pseudorandom test signal to said administering means causing a corresponding pseudorandom administration of said drug, and evaluating the corresponding pseudorandom component of said power response signal; and

(e) forming an error signal as the difference between said order signal and said power response signal, and applying this error signal to electronic means having a combined proportional and integral operating mode for establishing the relative magnitudes of said proportional and integral factors in response to a predetermined function of said drug/subject system model as determined by said evaluated pseudorandom component of said power response signal.

7. The method of claim 6 wherein said administered drug is thiopental.

8. The method of claim 6 wherein said drug is administered intravenously.

9. The method of claim 6 wherein the determining step further comprises the quantitative determination of the equation relating drug administration to the subject'"'"'s response as outlined by ##EQU5## where B_u is the ultimate gain, and u(t-T_d) symbolizes a unit step function with a time delay T_d, M is the drug dose rate, and S is the slope of the response curve at its point of inflection.

10. The method of claim 9 wherein the determining step further comprises establishing the relative magnitudes of said proportional and integral components by a predetermined function of the determined B_u, T_d and S.

11. The method of claim 10 further comprising the step of forming an error signal as the difference between said order signal and said response signal and applying this error signal to electronic means having a combined proportional plus integral plus derivative operating mode for establishing the relative magnitudes of said proportional, integral and derivative factors in response to a predetermined function of said drug/subject system model as determined by said pseudorandom component of said power response signal.